Replies to post #176141 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

You would think so.

The company has also successfully activated 75% of all planned clinical study sites representing 9 clinical trial sites for the Phase 2b/3 ANAVEX2-73 Alzheimer disease study. Enrollment and dosing of patients is currently proceeding as planned.

Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q4 2018 Results - Earnings Call Transcript